Published online Mar 14, 2020. doi: 10.3748/wjg.v26.i10.1080
Peer-review started: December 4, 2019
First decision: December 30, 2019
Revised: January 10, 2020
Accepted: February 15, 2020
Article in press: February 15, 2020
Published online: March 14, 2020
Processing time: 101 Days and 13.8 Hours
Endoscopic balloon dilatation (EBD) has become the first line of therapy for benign esophageal strictures (ESs); however, there are few studies on the predictive factors for outcomes of EBD treatment for anastomotic strictures after esophageal atresia (EA) repair in pediatric patients.
We aimed to perform a retrospective cohort analysis to help choose the optimal time for EBD treatment for anastomotic strictures after EA repair in pediatric patients.
Our analysis aimed to evaluate the response, safety, and predictive factors for the outcome of EBD treatment for ESs.
This is a monocentric retrospective cohort analysis. Patients treated by EBD for benign stricture after thoracoscopic EA repair in Shenzhen Children's Hospital from January 2012 to December 2016 were included. The demographic features, characteristics of the strictures, and outcomes were recorded. The response, complications, and recurrence rates were comparatively evaluated, and the risk factors were analyzed.
The number of dilatation sessions and complications were significantly greater in patients with smaller diameter strictures and with more than one stricture. The length of the stricture was significantly associated with complications of EBD. A longer interval between surgery and the first dilatation was related to more sessions and a poorer response.
The diameter, length, and number of strictures are the most important factors for the clinical outcomes of EBD in strictures after EA repair. The interval between surgery and the first EBD is a key factor for response and the number of sessions of dilatation.
Future studies analyzing safety and factors for the outcome of EBD treatment should focus on a comparison between strictures of different etiologies.